🇺🇸 FDA
Pipeline program

High-dosage SARS-CoV-2 vaccine

PRO-nCOV-4007

Approved mab active

Quick answer

High-dosage SARS-CoV-2 vaccine for COVID-19 is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
COVID-19
Phase
Approved
Modality
mab
Status
active

Clinical trials